NO962972L - Preparat for perkutan absorpsjon - Google Patents

Preparat for perkutan absorpsjon

Info

Publication number
NO962972L
NO962972L NO962972A NO962972A NO962972L NO 962972 L NO962972 L NO 962972L NO 962972 A NO962972 A NO 962972A NO 962972 A NO962972 A NO 962972A NO 962972 L NO962972 L NO 962972L
Authority
NO
Norway
Prior art keywords
derivative
preparation
percutaneous absorption
percutaneous
mixture
Prior art date
Application number
NO962972A
Other languages
English (en)
Norwegian (no)
Other versions
NO962972D0 (no
Inventor
Kaneto Uekama
Tetsumi Irie
Michio Hara
Yasuhide Horiuchi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO962972D0 publication Critical patent/NO962972D0/no
Publication of NO962972L publication Critical patent/NO962972L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO962972A 1994-11-17 1996-07-16 Preparat for perkutan absorpsjon NO962972L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28379394 1994-11-17
PCT/JP1995/002350 WO1996015793A1 (fr) 1994-11-17 1995-11-16 Preparation absorbable par voie percutanee

Publications (2)

Publication Number Publication Date
NO962972D0 NO962972D0 (no) 1996-07-16
NO962972L true NO962972L (no) 1996-09-16

Family

ID=17670220

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962972A NO962972L (no) 1994-11-17 1996-07-16 Preparat for perkutan absorpsjon

Country Status (15)

Country Link
US (1) US5854281A (fr)
EP (1) EP0742011B1 (fr)
JP (1) JP4024852B2 (fr)
KR (1) KR100413202B1 (fr)
CN (1) CN1102850C (fr)
AT (1) ATE220911T1 (fr)
AU (1) AU713461B2 (fr)
CA (1) CA2181364A1 (fr)
DE (1) DE69527507T2 (fr)
ES (1) ES2180658T3 (fr)
FI (1) FI962869L (fr)
NO (1) NO962972L (fr)
PT (1) PT742011E (fr)
TW (1) TW413637B (fr)
WO (1) WO1996015793A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0925788A4 (fr) * 1997-03-13 1999-12-01 Toray Industries Medicament pour traiter les lesions vasculaires diabetiques
US6448251B1 (en) * 1997-11-28 2002-09-10 Peter T. Pugliese Zwitterionic-fatty acid compounds having anti-inflammatory properties
US6114337A (en) * 1998-11-27 2000-09-05 Pugliese; Peter T. Zwitteronic-fatty acid compounds having anti-inflammatory properties
CA2335736A1 (fr) * 1998-06-25 1999-12-29 Lavipharm Laboratories, Inc. Dispositif et methode pour traiter la dyserection
US7658938B2 (en) * 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
BR0015802B1 (pt) * 1999-11-24 2014-04-29 Agile Therapeutics Inc Sistema de administração de contraceptivo transdérmico, e, método para produzir um sistema de administração de contraceptivo transdérmico
WO2002089853A2 (fr) * 2001-05-03 2002-11-14 Allergan, Inc. Compositions ayant des caracteristiques pharmacocinetiques ameliorees
EP1392272B1 (fr) 2001-05-11 2014-08-06 Merrion Research III Limited Renforcateur de permeation
CN101439039B (zh) 2003-05-09 2012-06-13 东丽株式会社 增强剂
WO2005067897A1 (fr) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Dispositif d'administration transdermique d'antagonistes calciques de type dihydropyridine renfermant au moins un acide gras
KR20080000647A (ko) * 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形
RU2517135C2 (ru) 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
US20130274352A1 (en) * 2009-04-14 2013-10-17 The Regents Of The University Of California Oral Drug Devices and Drug Formulations
AU2010339907A1 (en) 2009-12-16 2012-07-05 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
JP5878715B2 (ja) * 2011-09-22 2016-03-08 久光製薬株式会社 貼付剤
TWI569815B (zh) * 2012-03-22 2017-02-11 Teikoku Seiyaku Co Ltd Percutaneous absorption type preparation
US10335389B2 (en) 2013-08-09 2019-07-02 Teikoku Seiyaku Co., Ltd. Beraprost-containing patch
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
US20190343796A1 (en) * 2016-12-28 2019-11-14 Fujifilm Toyama Chemical Co., Ltd. Composition for external use
WO2023240105A1 (fr) * 2022-06-07 2023-12-14 Biomimetix Jv, Llc Compositions hydrophobes contenant un principe actif hydrophile et méthodes associées

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
ES2042527T3 (es) * 1986-11-14 1993-12-16 Theratech Inc Un metodo para preparar una composicion farmaceutica aumentadora de la penetracion para la aplicacion topica.
EP0375689B1 (fr) * 1987-06-01 1992-08-12 Warner-Lambert Company Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
JP2503672B2 (ja) 1989-07-28 1996-06-05 井関農機株式会社 草刈機の刈草収容装置
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
JP2838297B2 (ja) * 1989-11-02 1998-12-16 日産化学工業株式会社 コルヒチン含有外用剤
JPH082801B2 (ja) * 1989-11-09 1996-01-17 株式会社資生堂 経皮吸収促進剤及び皮膚外用剤
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JP3059204B2 (ja) * 1990-10-25 2000-07-04 帝國製薬株式会社 安定なプロスタグランジンｉ▲下１▼類含有皮膚適用組成物
JPH04243827A (ja) * 1991-01-25 1992-08-31 Sumitomo Pharmaceut Co Ltd プロスタグランジン誘導体含有溶解型軟膏剤
DE4124693A1 (de) * 1991-07-22 1993-01-28 Schering Ag Carbacyclinderivate als mittel zur behandlung von vitiligo
DE4124695C2 (de) * 1991-07-22 1994-12-22 Blitstein Willinger Eveline Dr Verwendung von Carbacyclinderivaten zur Behandlung von Psoriasis vulgaris
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
EP0583482B1 (fr) * 1992-02-07 1999-12-29 Kaken Pharmaceutical Co., Ltd. Remede destine aux blessures ou aux hemorroides
JP3102141B2 (ja) * 1992-05-29 2000-10-23 東レ株式会社 養毛育毛剤
JP3115482B2 (ja) * 1994-01-28 2000-12-04 帝人株式会社 プロスタサイクリン類含有皮膚適用組成物

Also Published As

Publication number Publication date
AU3881195A (en) 1996-06-17
NO962972D0 (no) 1996-07-16
TW413637B (en) 2000-12-01
ES2180658T3 (es) 2003-02-16
AU713461B2 (en) 1999-12-02
FI962869A7 (fi) 1996-09-16
DE69527507D1 (de) 2002-08-29
CA2181364A1 (fr) 1996-05-30
DE69527507T2 (de) 2002-11-07
ATE220911T1 (de) 2002-08-15
JP4024852B2 (ja) 2007-12-19
EP0742011A4 (fr) 1997-08-20
EP0742011B1 (fr) 2002-07-24
KR100413202B1 (ko) 2004-04-13
CN1102850C (zh) 2003-03-12
WO1996015793A1 (fr) 1996-05-30
CN1140412A (zh) 1997-01-15
FI962869L (fi) 1996-09-16
EP0742011A1 (fr) 1996-11-13
PT742011E (pt) 2002-10-31
FI962869A0 (fi) 1996-07-16
US5854281A (en) 1998-12-29

Similar Documents

Publication Publication Date Title
NO962972L (no) Preparat for perkutan absorpsjon
NO2011006I1 (no) Pitavastin, valgfritt i form av av farmasøytisk akseptabelt salt eller ester
MA18664A1 (fr) Derives d'amino-acides utiles comme agents contre l'hypertension
NO923809D0 (no) Farmasoeytisk preparat
CA2124690A1 (fr) Composition contenant une preparation du facteur de coagulation viii, methode de preparation et utilisation d'un surfactant comme stabilisateur
ES2153385T3 (es) Composicion acuosa a base de hormona del crecimiento humana.
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
ES2102919T3 (es) Composicion acida a base de vesiculas lipidicas y su utilizacion en aplicacion topica
BG48811A3 (bg) Метод за получаване на 2-бром-алфа-ергокриптини
EP0326357A3 (fr) Dérivés d'avermectine
PT1039895E (pt) Utilizacao de acidos 3-benzoilfenilaceticos respectivos esteres ou amidas para o tratamento do glaucoma glc1a
CA2005811A1 (fr) Composition cosmetique
NO995928L (no) Alfa-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
ES2159919T3 (es) Procedimiento para la preparacion de compuestos de tipo ceramidas.
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
CA2315871A1 (fr) Procedes, compositions et trousses pour stimuler le desir et la sensibilite sexuels chez la femme
ATE117207T1 (de) Stabile azelastinhydrochlorid-zubereitung.
AU1438699A (en) Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
NO991731L (no) Lokalanestetika for utvortes bruk
DK0646593T3 (da) Corticoid-17,21-dicarboxylsyreestere, fremgangsmåder til deres fremstilling og lægemidler indeholdende dem
CA2141788A1 (fr) Liberation retard de formulations pharmaceutiques de 3'-azido-3'-desoxythymidine et methodes d'utilisation
US5519054A (en) Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
EP0757987A4 (fr) Derive de l'acide pyrazolecarboxylique et agent de lutte contre les maladies vegetales
Bonina et al. Naproxen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vitro evaluation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application